Individuals should be aware of hypoglycaemia symptoms (shakiness, sweating, confusion, palpitations) and seek prompt medical attention if these occur
Many people find that these side effects improve over time as their bodies adjust
Afonina IS, Zhong Z, Karin M, Beyaert R
In fact, obesity treatment guidelines emphasize that GLP-1 medication should be combined with a high-protein diet, increased physical activity, and behavioral interventions (self-tracking, therapy, group support, dietary education, etc.)
Ongoing monitoring and follow-up should include regular re-assessment of dietary intake and hydration, for example, using food logs and/or food photos, and re-assessment of nutrient levels, using clinically accepted methodologies, during therapy to identify and promptly address emerging deficiencies
Patient Assistance Programs The Novo Nordisk Patient Assistance Program (PAP) provides semaglutide free of cost to qualifying patients